Immunotherapy in GU Cancers

Mark A. Rubin, MD

Special Reports, Immunotherapy (Issue 5), Volume 5, Issue 1

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

Mark A. Rubin, MD, director, Institute for Precision Medicine, Weill Cornell Medical College, discusses immunotherapy in the field of genitourinary cancers.

<<<

View the entire Special Report on Immunotherapy